Patents by Inventor Peter S. Conti

Peter S. Conti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • [18F]-furanosylpurine derivatives and uses thereof
    Patent number: 7273600
    Abstract: 2?-Deoxy-2?-[18F]-labeled and 3?-deoxy-3?-[18F]-labeled purine nucleoside analogs such as [18F]-FAA and [18F]-FXA have been found to have desirable properties for use as imaging agents. The analogs are particularly useful for in vivo imaging of biological material including organ tissues (e.g., heart, liver, brain and kidneys) and tumors. Methods for the preparation of the [18F]-FAA and [18F]-FXA are also provided.
    Type: Grant
    Filed: April 23, 2004
    Date of Patent: September 25, 2007
    Assignee: University of Southern California
    Inventors: Peter S. Conti, Mian M. Alauddin, John D. Fissekis
  • Method for expedient synthesis of [18F]-labeled ?-trifluoromethyl ketones
    Patent number: 6872855
    Abstract: The present invention is directed to a convenient method of synthesizing radiolabeled ?-trifluoromethyl ketones by a fluorination reaction. The present invention also relates to imaging agents and markers for identifying cell proliferation, or viral infection. The markers and imaging agents including the radiolabeled ?-trifluoromethyl ketones that are prepared by the present method.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: March 29, 2005
    Assignee: University of Southern California
    Inventors: G. K. Surya Prakash, Mian M. Alauddin, Jinbo Hu, Peter S. Conti, George A. Olah
  • [18F]-furanosylpurine derivatives and uses thereof
    Publication number: 20040265232
    Abstract: 2′-Deoxy-2′-[18F]-labeled and 3′-deoxy-3′-[18F]-labeled purine nucleoside analogs such as [18F]-FAA and [18F]-FXA have been found to have desirable properties for use as imaging agents. The analogs are particularly useful for in vivo imaging of biological material including organ tissues (e.g., heart, liver, brain and kidneys) and tumors. Methods for the preparation of the [18F]-FAA and [18F]-FXA are also provided.
    Type: Application
    Filed: April 23, 2004
    Publication date: December 30, 2004
    Inventors: Peter S. Conti, Mian M. Alauddin, John Fissekis
  • 2?-deoxy-2?-fluoro-d-arabinofuranosyl pyrimidine nucleoside
    Patent number: 6331287
    Abstract: The nucleoside analog 2′-fluoro-5-methyl-1-&bgr;-D-arabinofuranosyluracil (FMAU) has been found to have an especially desirable combination of properties for use as an imaging agent, including in particular limited in vivo catabolism. Methods for the preparation of the [11C]-and [18F]-labeled FMAU and for the use of the labeled material are also provided.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: December 18, 2001
    Assignee: University Advanced Bio-imaging Associates
    Inventors: Peter S. Conti, Mian M. Alauddin, John D. Fissekis
  • Imaging agents and methods for the preparation and use thereof
    Patent number: 5879661
    Abstract: The nucleoside analog 2'-fluoro-5-methyl-1-.beta.-D-arabinofuranosyluracil (FMAU) has been found to have an especially desirable combination of properties for use as an imaging agent, including in particular limited in vivo catabolism. Methods for the preparation of the ?.sup.11 C!-labelled FMAU and for the use of the labelled material are also provided.
    Type: Grant
    Filed: August 23, 1995
    Date of Patent: March 9, 1999
    Assignee: University Advanced Bio-Imaging Associates
    Inventors: Peter S. Conti, Mian M. Alauddin, John D. Fissekis